Sagar Kansara

Prof. Sagar Kansara

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2025 in Cancers
Verified
Journal Article
Open access
PDF file
JHJacob Hagen
Jacob Hagen
LHLogan Hornung
Logan Hornung
WBWilliam Barham
William Barham
SMSupratik Mukhopadhyay
Supratik Mukhopadhyay
ABAdam Bess
Adam Bess
SKSagar Kansara
Sagar Kansara
Head and neck cancer (HNC) encompasses malignant neoplasms originating from the soft tissues of the nasal cavity, paranasal sinuses, oral cavity, pharynx, larynx, skin, and thyroid

5 January 2025 in Cancers
Verified
Journal Article
Open access
PDF file
WBWilliam T. Barham
William T. Barham
MSMarshall Patrick Stagg
Marshall Patrick Stagg
RMRula Mualla
Rula Mualla
MDMichael DiLeo
Michael DiLeo
SKSagar Kansara
Sagar Kansara
Background: Head and neck cancer is a deadly disease with over 500,000 cases annually worldwide. Metastatic head and neck cancer accounts for a large proportion of the mortality associated with this disease. Many advances have been made in our understanding of the mechanisms of metastasis. The application of immunotherapy to locally recurrent or metastatic head and neck cancer has not only improved oncologic outcomes but has also provided valuable insights into the mechanisms of immune evasion and ultimately treatment failure. Objectives: This review paper will review our current understanding of biological mechanisms of treatment failure and metastasis. Published and ongoing clinical trials in the management of metastatic head and neck cancer will also be summarized. Methods: A narrative review was conducted to address the current understanding of the mechanisms of treatment failure and current treatment paradigms in recurrent and metastatic head and neck carcinoma. Conclusions: Our understanding of treatment failure in this disease is rapidly evolving. Immunotherapy represents a valuable new tool in the fight against recurrent and metastatic head and neck squamous cell carcinoma. Integrating patient and tumor specific data via artificial intelligence and deep learning will allow for a precision oncology approach, thereby achieving better prognostication and management of patients with this deadly disease.

22 May 2023 in Clinical Otolaryngology
Verified
Journal Article
Closed access
AGArushi Gulati
Arushi Gulati
KPKarolina Plonowska‐Hirschfeld
Karolina Plonowska‐Hirschfeld
ESErika M. Stephens
Erika M. Stephens
SKSagar Kansara
Sagar Kansara
AZAaron L. Zebolsky
Aaron L. Zebolsky
WRWilliam R. Ryan
William R. Ryan

28 March 2024 in Case Reports in Clinical Radiology
Verified
Journal Article
Open access
CIChad Pierre Issa
Chad Pierre Issa
ANAmberly Nunez
Amberly Nunez
RMRula Mualla
Rula Mualla
SKSagar Kansara
Sagar Kansara
Extranodal lymphomas (ENLs) are relatively rare malignancies of the head and neck. Clinical presentation varies greatly depending on location, pattern of nodal involvement, and histologic subtype. The most frequently involved sites include the palatine tonsils and nasal cavity/paranasal sinuses, and over half of patients have concurrent nodal disease. Most are non-Hodgkin’s lymphomas of B-cell lineage. While the clinical presentation may mimic other pathologies of the head and neck, various radiographic features and patterns may help raise suspicion for ENL as a differential consideration. This is of critical importance given that the management and treatment of lymphomas differ significantly from other pathologies of the head and neck. In this case series, three cases of ENL in the head and neck are described, with an emphasis on radiographic findings. A review of epidemiology and treatment paradigms is also provided.

2 July 2026 in Head & Neck
Verified
Journal Article
Open access
PDF file
VHVanessa Helou
Vanessa Helou
PRPooja D. Reddy
Pooja D. Reddy
PRPurva H. Rumde
Purva H. Rumde
MKMary L. Klem
Mary L. Klem
SKSagar Kansara
Sagar Kansara
KCKevin J. Contrera
Kevin J. Contrera
Background: Radiation‐induced fibrosis is a common, often debilitating late effect of head and neck cancer (HNC) treatment. An updated systematic review is needed to evaluate the reliability, validity, and clinical utility of fibrosis measurement tools. Methods: Cochrane Library, Medline, Embase.com , and Web of Science were systematically searched. Articles were independently screened by two reviewers using COSMIN checklists for risk of bias assessment, following PRISMA guidelines. Results: Of 4678 articles, 17 studies describing 13 tools met inclusion: six studies assessed four patient‐reported outcome measures, two assessed two clinician‐reported tools, and nine assessed seven imaging modalities. The Neck Fibrosis Scale, HN‐LEF Symptom Inventory, and LENT‐SOMA demonstrated validity and reliability. Young's modulus was the only imaging tool demonstrating both. Imaging studies had a higher risk of bias. Conclusion: Several subjective tools are reliable and valid for radiation‐induced fibrosis assessment in HNC. Young's modulus is the only objective imaging‐based tool that provides evidence of both validity and reliability, though methodological limitations remain.